PINPOINT: Gaming technology to engage adolescent sickle cell patients in precision pain Phase I
PINPOINT:游戏技术让青少年镰状细胞病患者参与精准疼痛第一阶段
基本信息
- 批准号:9789059
- 负责人:
- 金额:$ 63.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-01-12 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:17 year oldAbnormal HemoglobinsAcuteAddressAdolescentAdultAffectAfrican AmericanAgeArteriesBlood VesselsBlood flowCaringCellular PhoneChildChildhoodClinicalCognitiveCommunicationComorbidityDataDevelopmentDevelopment PlansDiseaseErythrocytesEstheticsEvaluationExperimental DesignsFamilyFamily memberFocus GroupsFrequenciesFutureGenetic DiseasesHealthHealthcareHematological DiseaseHemoglobinHispanicsHospitalizationHourIndividualInformation SystemsInheritedKnowledgeKnowledge acquisitionLearningLeftLifeMeasurementMeasuresMechanicsMedicalMethodsMorbidity - disease rateOrganOrgan failureOutcomePainPain Assessment ToolPain MeasurementPain intensityPain managementPaperParentsPatient Outcomes AssessmentsPatient Self-ReportPatientsPersonal SatisfactionPhasePlayProviderQuality of lifeQuestionnairesReporterReportingResearchSelf CareSelf EfficacySeveritiesSickle CellSickle Cell AnemiaSickle HemoglobinSmall Business Innovation Research GrantStrokeSuggestionSymptomsTablet ComputerTabletsTechnologyTeenagersTestingThinkingTimeTissuesTranslatingTreatment outcomeWorkacute chest syndromeassociated symptombasecare providersclinically significantcognitive abilitycognitive interviewcohesioncommercializationdesigndiariesdigitaleffective therapyexperiencehealth care service utilizationimprovedinnovationmobile applicationmortalitynovel strategiespain scorepain symptompediatric patientsphase 1 studyprogramsprototyperesearch and developmentresponsesatisfactionsicklingskill acquisitionskillssocialtechnological innovationtooltreatment choiceusability
项目摘要
Sickle cell disease (SCD) is the most common inherited blood disorder in the U.S. and disproportionately
affects African Americans and Hispanics. Approximately, 1,000 U.S. children are born with SCD annually. SCD
results from abnormal hemoglobin and causes red blood cells (RBCs) to become misshaped (“sickle-shaped”).
Sickled cells can block the flow of blood in small arteries causing tissue and organ damage and other life-
threatening comorbidities. SCD complications can be serious and have a significant impact upon well-being
and quality of life. Pain is the hallmark symptom associated with SCD, and is the most common clinical
problem seen in children and the number one cause of SCD-related hospital admissions. If left untreated, these
painful episodes can result in morbidity and mortality. Accurate assessment of pain specifiers (type, frequency,
and intensity of pain) can help with ameliorating pain quickly and effectively. Despite children being accurate
self-reporters of their pain, strategies which are effective and engaging to assist with pain identification and
communication of pain are lacking. In a Phase I SBIR, our team examined the feasibility and acceptability of a
gamified tablet application (Pinpoint) intended to encourage teens to talk about and assess their SCD pain. The
Phase I specific aims were : (1) work with an Expert Advisory Board (EAB) of experts to develop a new pain
assessment tool (PAT) to engage adolescent SCD patients, improve pain specification by patients, and improve
pain management by clinicians; (2) conduct cognitive interviews and focus groups with 13-17 year old SCD
patients to guide and refine development of app content, design, and aesthetics to fully develop a functioning
prototype; (3) conduct usability testing with 13-17 year old SCD patients to assess functionality, navigation, and
satisfaction; (4) conduct cognitive interviews with medical providers to provide input on app content, perceived
barriers to use, and its potential for clinical use and integration to inform future implementation; and (5)
develop a specifications document to outline the Phase II development plan. Deliverables were met and
feasibility was confirmed by the EAB. The proposed Phase II project will (1) develop a fully programmed,
interactive Pinpoint app consisting of 5 modules addressing pain identification and communication; (2)
conduct usability testing of Pinpoint to evaluate the user interface, ease of use, and perceived barriers in order
to optimize the app prior to large scale evaluation (n=14); and (3) test the full app with 13-17 year olds with
SCD (n=100) using a within-subjects design to evaluate changes in (a) knowledge acquisition for
communicating about pain and types of pain; (b) the Pain Assessment; (c) SCD general knowledge and self-
efficacy; (d) family cohesion; and (e) app usage. Overall, the proposed project has the potential to significantly
impact the health of SCD teens by providing important skill acquisition for communicating about and
identifying pain. This project is innovative and timely. Pinpoint will be the first tablet app to identify and
translate specific pain types for SCD into a gamified app using applied gamification principles.
镰状细胞病 (SCD) 是美国最常见的遗传性血液疾病,且发病率不成比例
每年大约有 1,000 名美国儿童出生时患有 SCD。
由血红蛋白异常引起,并导致红细胞 (RBC) 变形(“镰刀形”)。
镰状细胞可以阻塞小动脉中的血液流动,导致组织和器官损伤以及其他生命-
威胁性的 SCD 并发症可能很严重,并对健康产生重大影响。
疼痛是与 SCD 相关的标志症状,也是最常见的临床症状。
如果不及时治疗,这些问题是儿童中常见的问题,也是导致 SCD 相关住院的首要原因。
准确评估疼痛指标(类型、频率、
尽管儿童准确,但可以帮助快速有效地缓解疼痛。
自我报告他们的疼痛,有效且有吸引力的策略来协助疼痛识别和
在第一阶段 SBIR 中,我们的团队检查了疼痛的可行性和可接受性。
游戏化平板电脑应用程序 (Pinpoint) 旨在鼓励青少年谈论和评估他们的 SCD 疼痛。
第一阶段的具体目标是:(1) 与专家咨询委员会 (EAB) 合作开发一种新的疼痛方法
评估工具 (PAT) 吸引青少年 SCD 患者,提高患者的疼痛规范,并改善
(2) 对13-17岁的SCD进行认知访谈和焦点小组
患者指导和完善应用程序内容、设计和美学的开发,以充分开发功能
原型;(3) 对 13-17 岁的 SCD 患者进行可用性测试,以评估功能、导航和
(4) 与医疗服务提供者进行认知访谈,以提供有关应用程序内容、感知的信息
使用障碍及其临床使用和整合的潜力,为未来的实施提供信息;(5)
制定规范文件来概述第二阶段开发计划的实现和交付成果。
拟议的第二阶段项目的可行性已得到 EAB 的确认。
交互式 Pinpoint 应用程序由 5 个模块组成,解决疼痛识别和沟通问题 (2)
对 Pinpoint 进行可用性测试,以评估用户界面、易用性和感知障碍,以便
在大规模评估之前优化应用程序 (n=14);以及 (3) 与 13-17 岁的人一起测试完整的应用程序
SCD (n=100) 使用受试者内设计来评估 (a) 知识获取方面的变化
(b) 疼痛评估 (c) SCD 常识和自我评估;
功效;(d) 家庭凝聚力;以及 (e) 应用程序的使用 总体而言,拟议的项目具有显着的潜力。
通过提供重要的沟通和交流技能来影响 SCD 青少年的健康
Pinpoint 是第一个识别疼痛的平板电脑应用程序。
使用应用的游戏化原理将 SCD 的特定疼痛类型转化为游戏化应用程序。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Julia Berteletti其他文献
Julia Berteletti的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
针挑督脉改善血红蛋白alpha、beta亚基异常分子结构及红细胞携氧-释氧热力学、动力学治疗肿瘤相关性疲劳的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MIB2泛素化降解SUZ12参与调控阵发性睡眠性血红蛋白尿症异常克隆增殖的分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
阵发性睡眠性血红蛋白尿症克隆增殖相关分子异常研究
- 批准号:81400079
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
应用高分辨熔解曲线技术快速诊断血红蛋白病
- 批准号:81101329
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
异常血红蛋白分子病理学研究
- 批准号:38770110
- 批准年份:1987
- 资助金额:3.0 万元
- 项目类别:面上项目
相似海外基金
A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
- 批准号:
10564553 - 财政年份:2023
- 资助金额:
$ 63.16万 - 项目类别:
Pharmacologic Inhibition of NLRP3 Inflammasome-Dependent Injury following Vaso-occlusion in Sickle Cell Disease
镰状细胞病血管闭塞后 NLRP3 炎症小体依赖性损伤的药理学抑制
- 批准号:
10258844 - 财政年份:2021
- 资助金额:
$ 63.16万 - 项目类别:
Sickle Cell Improvement: ENhancing Care in the Emergency Department (SCIENCE)
镰状细胞病的改善:加强急诊科的护理(科学)
- 批准号:
10855133 - 财政年份:2021
- 资助金额:
$ 63.16万 - 项目类别:
Sickle Cell Improvement: ENhancing Care in the Emergency Department (SCIENCE)
镰状细胞病的改善:加强急诊科的护理(科学)
- 批准号:
10311624 - 财政年份:2021
- 资助金额:
$ 63.16万 - 项目类别:
Ghana-SPARCO: Ghana Sickle Pan-African Research Consortium
加纳-SPARCO:加纳镰刀泛非研究联盟
- 批准号:
10625460 - 财政年份:2021
- 资助金额:
$ 63.16万 - 项目类别: